IL79661A - Antiviral composition containing hypericin or pseudohypericin - Google Patents

Antiviral composition containing hypericin or pseudohypericin

Info

Publication number
IL79661A
IL79661A IL79661A IL7966186A IL79661A IL 79661 A IL79661 A IL 79661A IL 79661 A IL79661 A IL 79661A IL 7966186 A IL7966186 A IL 7966186A IL 79661 A IL79661 A IL 79661A
Authority
IL
Israel
Prior art keywords
pseudohypericin
composition containing
hsv
hypericin
antiviral composition
Prior art date
Application number
IL79661A
Other languages
English (en)
Other versions
IL79661A0 (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL79661A priority Critical patent/IL79661A/xx
Priority to AT87111467T priority patent/ATE96663T1/de
Priority to ES87111467T priority patent/ES2061453T3/es
Priority to DE87111467T priority patent/DE3788016T2/de
Priority to EP87111467A priority patent/EP0256452B1/de
Publication of IL79661A0 publication Critical patent/IL79661A0/xx
Priority to US07/328,767 priority patent/US5047435A/en
Priority to US07/452,436 priority patent/US5049589A/en
Publication of IL79661A publication Critical patent/IL79661A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL79661A 1986-08-08 1986-08-08 Antiviral composition containing hypericin or pseudohypericin IL79661A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL79661A IL79661A (en) 1986-08-08 1986-08-08 Antiviral composition containing hypericin or pseudohypericin
AT87111467T ATE96663T1 (de) 1986-08-08 1987-08-07 Antivirale pharmazeutische zusammensetzungen enthaltende hypericine oder pseudohypericine.
ES87111467T ES2061453T3 (es) 1986-08-08 1987-08-07 Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
DE87111467T DE3788016T2 (de) 1986-08-08 1987-08-07 Antivirale pharmazeutische Zusammensetzungen enthaltende Hypericine oder Pseudohypericine.
EP87111467A EP0256452B1 (de) 1986-08-08 1987-08-07 Antivirale pharmazeutische Zusammensetzungen enthaltende Hypericine oder Pseudohypericine
US07/328,767 US5047435A (en) 1986-08-08 1989-03-27 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
US07/452,436 US5049589A (en) 1986-08-08 1989-12-19 Antiviral aerosol compositions and pressurized containers containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79661A IL79661A (en) 1986-08-08 1986-08-08 Antiviral composition containing hypericin or pseudohypericin

Publications (2)

Publication Number Publication Date
IL79661A0 IL79661A0 (en) 1987-08-31
IL79661A true IL79661A (en) 1991-01-31

Family

ID=11057015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79661A IL79661A (en) 1986-08-08 1986-08-08 Antiviral composition containing hypericin or pseudohypericin

Country Status (6)

Country Link
US (2) US5047435A (de)
EP (1) EP0256452B1 (de)
AT (1) ATE96663T1 (de)
DE (1) DE3788016T2 (de)
ES (1) ES2061453T3 (de)
IL (1) IL79661A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056961A (en) * 1996-12-15 2000-05-02 Lavie; David Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
US6428819B1 (en) 1996-12-15 2002-08-06 David Lavie Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
DE332679T1 (de) * 1987-08-10 1990-04-12 New York University, New York, N.Y. Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
AU3294289A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
WO1989009056A1 (en) * 1988-03-23 1989-10-05 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
IL93682A (en) * 1989-03-16 1996-06-18 Yeda Res & Dev Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5316768A (en) 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
AU3474593A (en) * 1992-01-16 1993-08-03 New York University Hypericin treatment of vaccine agents for improved immunogenicity
JPH08505054A (ja) * 1992-12-23 1996-06-04 アイオア ステート ユニバーシティー リサーチ ファンデーション インコーポレーテッド 分子フラッシュ
DE9316320U1 (de) * 1993-10-20 1994-01-20 Beni Med Natuerliche Heilmitte Kosmetische Zubereitung in Form von Lippenstiften mit antiviraler Wirkung
DE19547317A1 (de) * 1995-12-18 1998-12-24 Dreluso Pharm Dr Elten & Sohn Antivirales Medikament
GR1002799B (el) * 1996-11-19 1997-11-04 Αντιικη δραση του φυτου hypericum perforatum l. κατα του ανθρωπινου κυτταρομεγαλοιου.
DE19700788A1 (de) * 1997-01-11 1998-07-16 Michael O Ruepp Johanniskraut-Trockenextrakte
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
JP2002509111A (ja) * 1998-01-13 2002-03-26 レクソール サンダウン インコーポレイテッド オトギリソウ及びメチル供与体組成物、並びにその使用
US6238671B1 (en) 1998-04-22 2001-05-29 Bionorica Arzneimittel Gmbh Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use
US6159986A (en) * 1999-11-02 2000-12-12 Altman; David A. Compounds and therapy for resisting memory loss in humans
DE10131641A1 (de) 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
US7037534B2 (en) * 2001-10-24 2006-05-02 Aphios Corporation Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
RU2220730C2 (ru) * 2002-03-13 2004-01-10 ЦНИИ Стоматологии Способ лечения герпетического стоматита
WO2004047821A1 (en) * 2002-11-25 2004-06-10 New York University Methods for preventing phototoxic damage during photodynamic therapy
US20100048728A1 (en) * 2006-08-03 2010-02-25 Hy Biopharma Inc. Polycyclic dianthraquinones as inhibitors of inflammatory cytokines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US4209532A (en) * 1977-03-28 1980-06-24 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclohexane dione compounds and alkali metal and ammonium salts thereof
US4338122A (en) * 1979-09-26 1982-07-06 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione compounds and alkali metal and ammonium salts thereof
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
JPS59190921A (ja) * 1983-04-11 1984-10-29 Junko Nozaki 抗ウイルス活性物質

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056961A (en) * 1996-12-15 2000-05-02 Lavie; David Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
US6428819B1 (en) 1996-12-15 2002-08-06 David Lavie Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis

Also Published As

Publication number Publication date
IL79661A0 (en) 1987-08-31
EP0256452B1 (de) 1993-11-03
ES2061453T3 (es) 1994-12-16
DE3788016T2 (de) 1994-03-03
DE3788016D1 (de) 1993-12-09
ATE96663T1 (de) 1993-11-15
US5047435A (en) 1991-09-10
US5049589A (en) 1991-09-17
EP0256452A2 (de) 1988-02-24
EP0256452A3 (en) 1990-01-17

Similar Documents

Publication Publication Date Title
IL79661A (en) Antiviral composition containing hypericin or pseudohypericin
MY130035A (en) Antiviral compounds
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
EP0270317A3 (de) Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten
DE69323183D1 (de) Weitere indolderivate mit antiviraler wirkung
ATE63747T1 (de) Antivirale verbindungen.
CA2063417A1 (en) Antiviral composition
ATE36331T1 (de) Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung.
MX9203217A (es) Nucleosidos terapeuticos.
MY105855A (en) Therapeutic nucleotides.
FR2572286B1 (fr) Utilisation du 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide pour le traitement de maladies virales chez l'homme
RU94016333A (ru) Лекарственное средство для лечения вирусных заболеваний
CA2258675A1 (en) 2-cyclopenten-1-one as an inducer of hsp70
DE69013134D1 (de) Extrakte von acanthospermum hispidum-pflanzen.
Prober Ribavirin: A new weapon against respiratory viruses?.
Iafrate et al. In vitro antiherpetic activity of brivudin: effect of variable exposure times and evaluation of drug interaction
EP0459176A3 (en) Oligophosphates with antiviral activity
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу
MY101495A (en) Treatment of diseases caused by viruses
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
Szarmach et al. Clinical studies on the effectiveness of Wratizolin in the treatment of some dermatoses
Nikolaeva et al. Pathomorphological study of antiviral chemotherapeutic effectiveness of bonaphthon under experimental conditions
ITMI931196A1 (it) Glicoproteine da herpes virus e vaccini che le contengono
UA19759A (uk) Сукциhат біс-(етилового ефіру)-п-аміhометилбеhзойhої кислоти, який має противірусhу активhість по відhошеhhю до вірусів грипу, вісповакциhи, імуhодефіциту та герпесу, а також аhтитоксоплазмеhhу дію

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees